Simultaneous PETMR is promising for accurate staging of high risk breast cancer. PET demonstrates higher specificity, whereas DWI improves sensitivity for detecting smaller lesions, particularly in liver, brain, and lungs. A combined FDG PET DWI approach enhances overall diagnostic accuracy and improves lesion characterization and staging. Additionally, the combination of SUVmax and Ki-67 provides a reliable indicator of tumour aggressiveness.
Subramanyam et al. (Fri,) studied this question.